eJHaem (Feb 2022)
Transverse myelitis after anti‐CD19 directed CAR T cell therapy for relapsed large B cell lymphoma
- Semira Sheikh,
- Sepideh Mokhtari,
- Jeffrey A. Silverman,
- Kayla Reid,
- Rawan Faramand,
- Marco L. Davila,
- Norman Franke,
- Frederick L. Locke,
- Michael D. Jain,
- Daniel Wong,
- John G. Kuruvilla
Affiliations
- Semira Sheikh
- Division of Medical Oncology and Hematology University Health Network Toronto Canada
- Sepideh Mokhtari
- Department of Neuro‐Oncology Moffitt Cancer Center Tampa Florida USA
- Jeffrey A. Silverman
- Department of Hematology North York General Hospital Toronto Canada
- Kayla Reid
- Department of Hematology Moffitt Cancer Center Tampa Florida USA
- Rawan Faramand
- Department of Malignant Hematology Moffitt Cancer Center Tampa Florida USA
- Marco L. Davila
- Department of Blood & Marrow Transplant and Cellular Immunotherapy Moffitt Cancer Center Tampa Florida USA
- Norman Franke
- Division of Medical Oncology and Hematology Princess Margaret Hospital Toronto Canada
- Frederick L. Locke
- Department of Blood & Marrow Transplant and Cellular Immunotherapy Moffitt Cancer Center Tampa Florida USA
- Michael D. Jain
- Department of Blood & Marrow Transplant and Cellular Immunotherapy Moffitt Cancer Center Tampa Florida USA
- Daniel Wong
- Department of Neurology North York General Hospital Toronto Canada
- John G. Kuruvilla
- Division of Medical Oncology and Hematology Princess Margaret Hospital Toronto Canada
- DOI
- https://doi.org/10.1002/jha2.286
- Journal volume & issue
-
Vol. 3,
no. 1
pp. 223 – 227
Abstract
No abstracts available.Keywords